JPRN-jRCTb030200129RecruitingPhase 1
Clinical research for autologous-cultured epithelium sheet transplantation for vitiligo vulgaris - Autologous-cultured epithelium sheet for vitiligo vulgaris
ishikawa Ayaka0 sites5 target enrollmentStarted: September 24, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Enrollment
- 5
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- •(1)Patients who are over 20 years old and obtain consent in writing.
- •(2) Patients with a diagnosis of vitiligo vulgaris who have little or no effect on at least a few standard treatments
- •(3) Patients with stable vitiligo that has not progressed within the past year and does not show obvious Koebner phenomenon
Exclusion Criteria
- •(1) Patients being treated for autoimmune diseases
- •(2) Patients who are systemically administered steroids (corticosteroids)
- •(3) Patients with skin malignancy, patients with suspected skin malignancy, or patients with a history of skin malignancy less than 5 years
- •(4) Pregnant women, lactating women, patients who may be pregnant, patients who wish to become pregnant during the study period
- •(5) Patients with severe heart disease
- •(6) Patients with severe liver disease
- •(7) End stage renal failure
- •(8) Patients with severe blood coagulation disorder
- •(9) Person with active infection
- •(10) Persons with mental illness
- •(11) HCV antibody, HBs antigen, HTLV-1 virus antibody or HIV antibody positive
- •(12) Patients with allergic symptoms in cattle and mice
- •(13)Patients with vitiligo area that cannot be covered with Specific Cell Products to be transplanted
- •(14)Other patients who are determined to be inappropriate for participation in this study by the person in charge
Investigators
Similar Trials
Completed
Not Applicable
Grafts of autologous epithelial cells for non-healing mastoid cavities: a randomised clinical trialEar, nose and throat diseasesEar, Nose and ThroatISRCTN85732710HS R&D Regional Programme Register - Department of Health (UK)100
Completed
Not Applicable
Autologous mesenchymal cell implantation in patients with peripheral artery disease (Arteriosclerosis obliterans, Buerger's disease, collagen disease)Peripheral artery disease (arteriosclerosis obliterans, Buerger's disease, collagen disease)JPRN-UMIN000013820Showa University Fujigaoka Hospital10
Terminated
Phase 1
Mesenchymal Stromal Cells in Kidney Transplant RecipientsKidney Transplant RejectionNCT02012153Mario Negri Institute for Pharmacological Research3
Active, not recruiting
Phase 3
A clinical trial of dried allogeneic cultured epidermis (Allo-JaCE03) for deep dermal burJPRN-jRCT2052210214Hayashi Shigeaki15
Completed
Phase 1
Clinical study of autologous noncultured epidermal cell transplantation for leucodelma treatmentJPRN-jRCTc050190126Tanemura Atsushi5